Zobrazeno 1 - 10
of 10
pro vyhledávání: '"Tesfaye, Bekalu Amare"'
Autor:
Tesfaye, Bekalu Amare (AUTHOR), Berhe, Abera Hadgu (AUTHOR), Wondafrash, Dawit Zewdu (AUTHOR), Berhe, Derbew Fikadu (AUTHOR)
Publikováno v:
Journal of Experimental Pharmacology. Feb2021, Vol. 13, p147-160. 14p.
Autor:
Tesfaye, Bekalu Amare (AUTHOR), Hailu, Haftom Gebregergs (AUTHOR), Zewdie, Kaleab Alemayehu (AUTHOR), Ayza, Muluken Altaye (AUTHOR), Berhe, Derbew Fikadu (AUTHOR)
Publikováno v:
Journal of Experimental Pharmacology. Jan2021, Vol. 13, p23-31. 9p.
Autor:
Zewdie, Kaleab Alemayehu, Ayza, Muluken Altaye, Tesfaye, Bekalu Amare, Wondafrash, Dawit Zewdu, Berhe, Derbew Fikadu
Publikováno v:
Research and Reports in Urology
Background Erectile dysfunction (ED) is a common clinical condition with limited treatment options. The main aim of the present systematic review was to synthesize information on Rho-kinase as a novel therapeutic approach for the treatment of ED. Met
Publikováno v:
Clinical Pharmacology: Advances and Applications.
Kaleab Alemayehu Zewdie, Haftom Gebregergs Hailu, Muluken Altaye Ayza, Bekalu Amare Tesfaye Department of Pharmacology and Toxicology, School of Pharmacy, Mekelle University, Mekelle, EthiopiaCorrespondence: Kaleab Alemayehu Zewdie, Department of Pha
Autor:
Ayza, Muluken Altaye, Zewdie, Kaleab Alemayehu, Yigzaw, Elias Fitsum, Ayele, Solomon Gashaw, Tesfaye, Bekalu Amare, Tafere, Gebrehiwot Gebremedhin, Abrha, Muzey Gebreyohannes
Publikováno v:
International Journal of Nephrology.
Cyclophosphamide is an alkylating antineoplastic agent, and it is one of the most successful drugs with wide arrays of clinical activity. It has been in use for several types of cancer treatments and as an immunosuppressive agent for the management o
Autor:
Ayza,Muluken Altaye, Zewdie,Kaleab Alemayehu, Tesfaye,Bekalu Amare, Gebrekirstos,Selamawit Tesfamariam, Berhe,Derbew Fikadu
Publikováno v:
Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy.
Muluken Altaye Ayza, Kaleab Alemayehu Zewdie, Bekalu Amare Tesfaye, Selamawit Tesfamariam Gebrekirstos, Derbew Fikadu Berhe Department of Pharmacology and Toxicology, School of Pharmacy, Mekelle University, Mekelle, EthiopiaCorrespondence: Muluken Al
Autor:
Ayza, Muluken Altaye, Zewdie, Kaleab Alemayehu, Tesfaye, Bekalu Amare, Wondafrash, Dawit Zewdu, Berhe, Abera Hadgu
Publikováno v:
Oxidative Medicine and Cellular Longevity.
The chemotherapeutic and immunosuppressive agent cyclophosphamide has previously been shown to induce complications within the setting of bone marrow transplantation. More recently, cardiotoxicity has been shown to be a dose-limiting factor during cy
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Publikováno v:
Clinical Ophthalmology; Jun2020, Vol. 14, p1741-1747, 7p
Autor:
Zewdie KA; Department of Pharmacology and Toxicology, School of Pharmacy, Mekelle University, Mekelle, Ethiopia., Hailu HG; Department of Pharmacology and Toxicology, School of Pharmacy, Mekelle University, Mekelle, Ethiopia., Ayza MA; Department of Pharmacology and Toxicology, School of Pharmacy, Mekelle University, Mekelle, Ethiopia., Tesfaye BA; Department of Pharmacology and Toxicology, School of Pharmacy, Mekelle University, Mekelle, Ethiopia.
Publikováno v:
Clinical pharmacology : advances and applications [Clin Pharmacol] 2022 Feb 21; Vol. 14, pp. 11-17. Date of Electronic Publication: 2022 Feb 21 (Print Publication: 2022).